ID: ALA4585015

Max Phase: Preclinical

Molecular Formula: C12H16N2O3S

Molecular Weight: 268.34

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCn1c(=O)c2c(C)csc2n(CCOC)c1=O

Standard InChI:  InChI=1S/C12H16N2O3S/c1-4-13-10(15)9-8(2)7-18-11(9)14(12(13)16)5-6-17-3/h7H,4-6H2,1-3H3

Standard InChI Key:  GQKSFVDZUUBVNU-UHFFFAOYSA-N

Associated Targets(Human)

Adenosine A2b receptor 7672 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 268.34Molecular Weight (Monoisotopic): 268.0882AlogP: 1.20#Rotatable Bonds: 4
Polar Surface Area: 53.23Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.60CX LogD: 1.60
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.84Np Likeness Score: -1.85

References

1. Härter M, Kalthof B, Delbeck M, Lustig K, Gerisch M, Schulz S, Kast R, Meibom D, Lindner N..  (2019)  Novel non-xanthine antagonist of the A2B adenosine receptor: From HTS hit to lead structure.,  163  [PMID:30576906] [10.1016/j.ejmech.2018.11.045]

Source